课题基金 / 基金详情

Novel strategy to selectively target tumor cell growth and chemosensitivity

Novel strategy to selectively target tumor cell growth and chemosensitivity
选择性靶向肿瘤细胞生长和化疗敏感性的新策略
批准号:
267149
负责人:
Batist Gerald
金额:
$55.93万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-09-01 至 2017-09-01

项目摘要

项目成果

Batist Gerald的其他基金

相关文献

中文摘要
翻译
癌症患者面临的最大威胁是肿瘤对治疗的抵抗力。克服阻力将对生存产生重大影响。我们正在研究一种细胞用来保护自己免受伤害的系统。肿瘤利用这个系统变得有抵抗力,
英文摘要
The greatest threat to cancer patients is resistance of tumors to treatment. Overcoming resistance will have a major impact on survival. We are studying a system that cells use to protect themselves from damage. Tumors use this system to become resistant,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2nd Quebec Conference on Therapeutic Resistance in Cancer